Assignee profile:

Alligator Bioscience AB

City:

Lund

Country:

Sweden

Published Applications:

36

Last publication date:

2024-04-25

Patent Grants:

34

Last grant date:

2026-03-10

Top Inventors for applications by Alligator Bioscience AB

These are the the leading inventors for applications assigned to Alligator Bioscience AB:

Recent patent applications by Alligator Bioscience AB

Alligator Bioscience AB based in Lund, SE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-04-25 ✅ Patent 12,570,753 granted on 2026-03-10
US20240132609A1
Chemistry; metallurgy

COMBINATION THERAPIES WITH ANTI CD40 ANTIBODIES

#2 | 2024-04-11 ✅ Patent 12,448,465 granted on 2025-10-21
US20240117074A1
Chemistry; metallurgy

PEPTIDES

#3 | 2024-01-04 ✅ Patent 12,415,862 granted on 2025-09-16
US20240002524A1
Chemistry; metallurgy

METHODS AND COMPOSITIONS

#4 | 2023-10-05 ✅ Patent 11,873,348 granted on 2024-01-16
US20230312754A1
Chemistry; metallurgy

Peptides

#5 | 2023-09-21 ✅ Patent 12,509,526 granted on 2025-12-30
US20230295325A1
Chemistry; metallurgy

NOVEL ANTI-CD137 ANTIBODIES AND USES THEREOF

#6 | 2022-07-07 ✅ Patent 12,173,082 granted on 2024-12-24
US20220213213A1
Chemistry; metallurgy

Bispecific polypeptides against CD137

#7 | 2022-02-24 ✅ Patent 12,570,759 granted on 2026-03-10
US20220056148A1
Chemistry; metallurgy

NOVEL POLYPEPTIDES

#8 | 2021-08-05 ✅ Patent 11,780,928 granted on 2023-10-10
US20210238298A1
Chemistry; metallurgy

Polypeptides

#9 | 2020-07-16 ✅ Patent 11,725,060 granted on 2023-08-15
US20200223933A1
Chemistry; metallurgy

Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methods

#10 | 2020-06-18 ✅ Patent 10,774,150 granted on 2020-09-15
US20200190208A1
Chemistry; metallurgy

Polypeptides

#11 | 2019-12-19 ✅ Patent 11,312,786 granted on 2022-04-26
US20190382503A1
Chemistry; metallurgy

Oncofetal antigen binding proteins and related compositions and methods

#12 | 2019-11-21 ✅ Patent 10,689,454 granted on 2020-06-23
US20190352414A1
Chemistry; metallurgy

Anti-CD137 antibodies and uses thereof

#13 | 2019-11-21 ✅ Patent 11,535,678 granted on 2022-12-27
US20190352411A1
Chemistry; metallurgy

Anti-CD137 antibodies and uses thereof

#14 | 2019-01-17 ✅ Patent 10,239,949 granted on 2019-03-26
US20190016816A1
Chemistry; metallurgy

Oncofetal antigen binding proteins and related compositions and methods

#15 | 2018-05-03 ✅ Patent 11,008,396 granted on 2021-05-18
US20180118841A1
Chemistry; metallurgy

Polypeptides

#16 | 2017-08-10 ✅ Patent 11,149,090 granted on 2021-10-19
US20170226217A1
Chemistry; metallurgy

Combination therapies with anti CD40 antibodies

#17 | 2017-01-05 ✅ Patent 10,414,815 granted on 2019-09-17
US20170002061A1
Chemistry; metallurgy

scFV antibody library

#18 | 2016-10-27 ✅ Patent 10,577,425 granted on 2020-03-03
US20160311916A1
Chemistry; metallurgy

Anti-CD40 antibodies

#19 | 2016-10-20 ✅ Patent 9,834,589 granted on 2017-12-05
US20160304580A1
Chemistry; metallurgy

CD86 variants with improved affinity for CTLA-4

#20 | 2014-11-27 ✅ Patent 9,676,862 granted on 2017-06-13
US20140348836A1
Chemistry; metallurgy

Anti-CD40 antibodies and methods of treating cancer

#21 | 2013-05-23 ✅ Patent 9,163,072 granted on 2015-10-20
US20130129672A1
Chemistry; metallurgy

Mutants of interleukin-1 receptor antagonist

#22 | 2013-01-31 ✅ Patent 9,486,520 granted on 2016-11-08
US20130028932A1
Human necessities

Compositions comprising polyglutamic acid nanoparticles and CD40 agonists

#23 | 2013-01-03 ✅ Patent 8,685,640 granted on 2014-04-01
US20130004483A1
Physics

Medical methods and agents for use therein

#24 | 2012-03-22 ✅ Patent 8,552,149 granted on 2013-10-08
US20120071394A1
Chemistry; metallurgy

Polypeptides and use thereof

#25 | 2010-11-25 ✅ Patent 8,173,774 granted on 2012-05-08
US20100298539A1
Chemistry; metallurgy

Polypeptides and use thereof

#26 | 2010-05-13 ✅ Patent 8,303,945 granted on 2012-11-06
US20100120684A1
Chemistry; metallurgy

Mutants of interleukin-1 receptor antagonist

#27 | 2010-02-16 ✅ Patent 7,662,551 granted on 2010-02-16
US10299362
-

Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules

#28 | 2009-11-12 ✅ Patent 7,816,085 granted on 2010-10-19
US20090280526A1
Chemistry; metallurgy

Method for in vitro molecular evolution of protein function

#29 | 2008-10-09 ✅ Patent 7,563,578 granted on 2009-07-21
US20080248533A1
Chemistry; metallurgy

Method for in vitro molecular evolution of protein function

#30 | 2008-10-02
US20080242605A1
Chemistry; metallurgy

CHEMOTAXIS-INHIBITING PROTEIN OF STAPHYLOCOCCUS (CHIPS) AND ITS USE

#31 | 2008-06-19 ✅ Patent 8,071,289 granted on 2011-12-06
US20080146461A1
Chemistry; metallurgy

Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules

#32 | 2006-12-26 ✅ Patent 7,153,655 granted on 2006-12-26
US10321195
-

Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence

#33 | 2006-07-27 ✅ Patent 7,262,012 granted on 2007-08-28
US20060166198A1
Chemistry; metallurgy

Method for in vitro molecular evolution of protein function using varied exonuclease digestion in two polynucleotide populations

#34 | 2006-01-26 ✅ Patent 7,282,334 granted on 2007-10-16
US20060019300A1
Chemistry; metallurgy

Method for in vitro molecular evolution of protein function

#35 | 2005-10-25 ✅ Patent 6,958,213 granted on 2005-10-25
US9734801
-

Method for in vitro molecular evolution of protein function

#36 | 2005-06-30
US20050143307A1
Chemistry; metallurgy

Chemotaxis-inhibiting protein of staphyloccocus (CHIPS) and its use

Also check out Alligator Bioscience AB's (Lund, Sweden) applicant profile with 24 patent applications submitted.

AssigneeID:

1525 ⎘